High STAT4 Expression Indicates Better Disease-free Survival in Patients with Gastric Cancer

Anticancer Res. 2017 Dec;37(12):6723-6729. doi: 10.21873/anticanres.12131.

Abstract

Background: The aim of this study was to investigate the significance of signal transducer and activator of transcription 4 (STAT4) expression and the correlation between STAT4 and interferon gamma (IFN-γ) in patients with gastric cancer.

Patients and methods: Sixty-two patients who underwent gastrectomy for gastric cancer were enrolled in the study. STAT4 and IFNG mRNA expression was evaluated by quantitative real-time polymerase chain reaction (PCR). Immunohistochemistry was performed to examine CD8+ T-cells, and STAT4 and IFN-γ expression.

Results: STAT4 mRNA expression was significantly correlated with IFNG mRNA expression (p<0.05). Regarding disease-free survival, there was a significant difference between the groups with high and low STAT4 expression (5-year disease-free survival: 77.8% and 56.4%, p<0.05). Univariate analysis revealed that tumor differentiation and STAT4 expression were significant factors for tumor recurrence.

Conclusion: High expression of STAT4 in gastric cancer predicted a better clinical outcome. STAT4 might be a useful biomarker to identify patients at high risk of recurrence after gastrectomy.

Keywords: IFN-γ; STAT4 gene; gastric cancer.

MeSH terms

  • Aged
  • Disease-Free Survival
  • Female
  • Gastrectomy / methods
  • Gene Expression Regulation, Neoplastic*
  • Humans
  • Interferon-gamma / genetics*
  • Interferon-gamma / metabolism
  • Kaplan-Meier Estimate
  • Male
  • Neoplasm Recurrence, Local
  • Outcome Assessment, Health Care
  • Prognosis
  • STAT4 Transcription Factor / genetics*
  • STAT4 Transcription Factor / metabolism
  • Stomach Neoplasms / genetics*
  • Stomach Neoplasms / metabolism
  • Stomach Neoplasms / surgery

Substances

  • STAT4 Transcription Factor
  • Interferon-gamma